During intraday trading, 3SBIO (1530.HK) once surged over 12%, reaching HKD 11.04, a price high since June 2021. The company announced last night that the profit for 2024 is approximately 2.09 billion yuan, up 34.9%, with earnings per share of 86 cents, and a final dividend of 25 HK cents per share, remaining unchanged. Revenue during the period was 9.1 billion yuan, up 16.5%; the gross margin increased by approximately 1 percentage point from last year to 86.06%; adjusted operating EBITDA was about 3.4 billion yuan, a rise of 22.9%. At the end of last year, the group was developing 30 key products.